News
News from us and our partners
Tags
Topics
0 results
- News
Sensorion Announces Approval of Clinical Trial Application in France for SENS-601, Its Investigational Gene Therapy for the Treatment of GJB2-Related Hearing Loss
- News
Biotalys Secures Product Registration in California for EVOCA®, Strengthening Regulatory Pathway for Its Lead Asset EVOCA NG
- News
Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
- News
Medtronic announces strategic investment in Pi-Cardia to accelerate innovation for complex TAVR
- News
AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer
- News
Inventiva Appoints Chris Benecchi as Chief Operating Officer
- News
Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize YUVEZZI in the European Union, the United Kingdom, Switzerland, Norway, and Iceland
- News
Galvanize Therapeutics® Announces the Latest Exploratory Evidence Suggesting Immune-Activating Potential of Aliya® PEF Energy
- News
MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies
- News
HotSpot Therapeutics appoints Niti Goel, M.D., as Chief Medical Officer
- News
Nitrase Therapeutics announces the appointment of three industry veterans to its Board of Directors
- News
Galvanize Therapeutics® Announces First Commercial Procedures Using the New Aliya® EX System
- News
Mediar Therapeutics enters into a collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases
- News
Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease
- News
HAYA Therapeutics receives FDA Fast Track Designation for HTX-001